TrianglePUBLICATIONS · 36332179
Margetuximab Versus Trastuzumab in Patients With Previously Treated HER2-Positive Advanced Breast Cancer (SOPHIA): Final Overall Survival Results From a Randomized Phase 3 Trial.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2023 Jan 10
- First author
- Rugo HS
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Rugo HS
- type
- Author
- name
- Im SA
- type
- Author
- name
- Cardoso F
- type
- Author
- name
- Cortes J
- type
- Author
- name
- Curigliano G
- type
- Author
- name
- Musolino A
- type
- Author
- name
- Pegram MD
- type
- Author
- name
- Bachelot T
- type
- Author
- name
- Wright GS
- type
- Author
- name
- Saura C
- type
- Author
- name
- Escrivá-de-Romaní S
- type
- Author
- name
- De Laurentiis M
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Rugo HS
- type
- Author
- name
- Im SA
- type
- Author
- name
- Cardoso F
- type
- Author
- name
- Cortes J
- type
- Author
- name
- Curigliano G
- type
- Author
- name
- Musolino A
- type
- Author
- name
- Pegram MD
- type
- Author
- name
- Bachelot T
- type
- Author
- name
- Wright GS
- type
- Author
- name
- Saura C
- type
- Author
- name
- Escrivá-de-Romaní S
- type
- Author
- name
- De Laurentiis M
- type
- Author
- bibliography ids
- nci-bib-bc74aa061d51fd5313cf6923
- book metadata
- content sha256
- 8de4ee2c589f8b19274d8d805dd53d3ab95d0634ddf8be8851f518fa85ac11bc
- document type
- citation
- dois
- 10.1200/JCO.21.02937
- electronic publication date
- display
- 2022 Nov 4
- precision
- day
- year
- 2022
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:36332179
- immutable id
- pubmed:36332179@8de4ee2c589f8b19274d8d805dd53d3ab95d0634ddf8be8851f518fa85ac11bc
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 2
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 198-205
- volume
- 41
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 36332179
- provenance
- batch id
- d370e99271168e8a8a13
- provider
- NCBI PubMed ESummary
- record sha256
- a5bfe4045bf43b5d54dba6152864fabb79974ea8dfc41dbb2e7c6fce85bc4d17
- response sha256
- f65ace3ceb1efa86f3fbab8e01ce265243e7c6b7f13c5f71c357c1f219ad79c4
- retrieved at
- 2026-09-09T23:48:13.005737+00:00
- publication date
- display
- 2023 Jan 10
- precision
- day
- year
- 2023
- publication types
- Randomized Controlled Trial
- Clinical Trial, Phase III
- Journal Article
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Margetuximab Versus Trastuzumab in Patients With Previously Treated HER2-Positive Advanced Breast Cancer (SOPHIA): Final Overall Survival Results From a Randomized Phase 3 Trial.
Preserved source evidence · Not medical advice